However, given the role and importance of ApoE4 in both cholesterol homeostasis and AD pathology, it may be highlighted as a target for clinical trials and future pharmacological interventions.
which combines to a receptor on the liver that inhibits “endogenous cholesterol synthesis” maintaining homeostasis or ...